Research ArticleLaboratory Studies
Quantitation of Myocardial Fatty Acid Metabolism Using PET
Steven R. Bergmann, Carla J. Weinheimer, Joanne Markham and Pilar Herrero
Journal of Nuclear Medicine October 1996, 37 (10) 1723-1730;
Steven R. Bergmann
Carla J. Weinheimer
Joanne Markham


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Quantitation of Myocardial Fatty Acid Metabolism Using PET
Steven R. Bergmann, Carla J. Weinheimer, Joanne Markham, Pilar Herrero
Journal of Nuclear Medicine Oct 1996, 37 (10) 1723-1730;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Machine learning prediction of cancer cell metabolism from autofluorescence lifetime images
- MR/PET Imaging of the Cardiovascular System
- Myocardial Viability: Survival Mechanisms and Molecular Imaging Targets in Acute and Chronic Ischemia
- Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
- Noninvasive Imaging in the Assessment of the Cardiopulmonary Vascular Unit
- Free Fatty Acid Uptake in Humans With CD36 Deficiency
- Synthesis and Preliminary Evaluation of 18-18F-Fluoro-4-Thia-Oleate as a PET Probe of Fatty Acid Oxidation
- Imaging Myocardial Metabolic Remodeling
- Radionuclide Imaging of Myocardial Metabolism
- Altered Myocardial Substrate Metabolism and Decreased Diastolic Function in Nonischemic Human Diabetic Cardiomyopathy: Studies With Cardiac Positron Emission Tomography and Magnetic Resonance Imaging
- In Vivo Metabolic Phenotyping of Myocardial Substrate Metabolism in Rodents: Differential Efficacy of Metformin and Rosiglitazone Monotherapy
- Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus
- Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy
- Impact of Gender on the Myocardial Metabolic Response to Obesity
- Assessment of Myocardial Metabolism in Diabetic Rats Using Small-Animal PET: A Feasibility Study
- Increased Myocardial Fatty Acid Metabolism in Patients With Type 1 Diabetes Mellitus
- Validation of 18F-Fluoro-4-Thia-Palmitate as a PET Probe for Myocardial Fatty Acid Oxidation: Effects of Hypoxia and Composition of Exogenous Fatty Acids
- Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy
- Evaluation of trans-9-18F-Fluoro-3,4-Methyleneheptadecanoic Acid as a PET Tracer for Myocardial Fatty Acid Imaging
- Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women
- Impact of aging on substrate metabolism by the human heart
- Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease
- Synthesis and Initial Evaluation of 17-11C-Heptadecanoic Acid for Measurement of Myocardial Fatty Acid Metabolism
- Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy